Zikduce 10 Tablet contains Nicorandil 10mg, a potassium channel activator with nitrate-like properties used primarily in the management of angina pectoris. Nicorandil acts by dilating both the arterial and venous blood vessels, thereby reducing myocardial oxygen demand and improving coronary blood flow. This dual mechanism helps alleviate chest pain associated with stable angina and enhances exercise tolerance. Zikduce 10 is indicated for patients with chronic stable angina who remain symptomatic despite conventional therapy or those intolerant to other anti-anginal medications. The drug is administered orally, with dosage tailored according to clinical response and tolerability. Common adverse effects may include headache, flushing, dizziness, and gastrointestinal disturbances. Rare but serious side effects include ulceration and perforation of the gastrointestinal tract; therefore, patients should be monitored for any signs of abdominal pain or discomfort. Nicorandil should be used cautiously in patients with hypotension, severe renal or hepatic impairment, and in combination with other vasodilators. It is contraindicated in patients with hypersensitivity to Nicorandil or nitrate derivatives. Zikduce 10 Tablet should be prescribed under medical supervision, with regular evaluation to optimize therapeutic outcomes and minimize potential risks.